Fitchburg, WI, United States of America

Andrei V Blokhin

USPTO Granted Patents = 25 

 

 

Average Co-Inventor Count = 6.4

ph-index = 9

Forward Citations = 246(Granted Patents)


Location History:

  • Madison, WI (US) (2002 - 2009)
  • Fitchburg, WI (US) (2006 - 2023)

Company Filing History:


Years Active: 2002-2024

Loading Chart...
Loading Chart...
Loading Chart...
25 patents (USPTO):

Title: Andrei V. Blokhin: Innovator in Therapeutic Targeting Ligands

Introduction

Andrei V. Blokhin, based in Fitchburg, Wisconsin, is a distinguished inventor known for his significant contributions to the field of therapeutic compounds. With an impressive portfolio of 25 patents, Blokhin's work focuses primarily on advancing medical treatments through innovative targeting ligands that enhance the efficacy of therapeutic agents.

Latest Patents

Among his most recent patents are innovative targeting ligands that can be linked to therapeutic compounds, aimed at directing these compounds to specific targets in vivo. These ligands are particularly relevant for targeting expression-inhibiting oligomeric compounds, such as RNA interference (RNAi) agents, to liver cells, thus modulating gene expression. The disclosed ligands, when conjugated with expression-inhibiting oligomeric compounds, can facilitate various applications including therapeutics, diagnostics, target validation, and genomic discovery. In another pivotal patent, Blokhin explores compositions for inhibiting the expression of the Hif2α (EPAS1) gene, presenting RNAi triggers that can be delivered to tumor cells to treat cancer by effectively inhibiting Hif2α gene expression.

Career Highlights

Blokhin has made significant strides in the pharmaceutical sector, having worked for renowned companies such as Arrowhead Pharmaceuticals, Inc. and Arrowhead Madison, Inc. His expertise and innovative approach have allowed him to stay at the forefront of medical research and development, actively contributing to groundbreaking advancements in therapeutic techniques.

Collaborations

Throughout his career, Blokhin has collaborated with esteemed colleagues, including David B. Rozema and Jonathan D. Benson. These collaborations have not only amplified the impact of his work but have also fostered a productive environment for research and innovation within the pharmaceutical industry.

Conclusion

Andrei V. Blokhin's dedication to enhancing therapeutic strategies through innovative targeting ligands positions him as a notable figure in the realm of medical inventions. His extensive patent portfolio reflects not only his ingenuity but also his commitment to advancing medical science for the benefit of patients globally.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…